Nicola Zotta, President, Marchon Eyewear, Inc.

Nicola Zotta was named president of Marchon Eyewear, Inc., one of the world’s largest manufacturers and distributors of eyewear, in June 2016. With a seven-year tenure as Marchon’s managing director for Europe, the Middle East, and Africa, Zotta has expertise in go-to market strategies and product and supply chain optimization.

Here, Zotta sits down with EB to discuss his role with Marchon, and the opportunities the company presents for eyecare professionals.

What are your goals for Marchon in the U.S.?

We’re already one of the most prominent leaders in eyewear in the U.S. But our teams and representatives in the field are motivated to reach our goal to become the most admired eyewear manufacturer, known for captivating consumers, doctors, partners, and employees alike. Achieving this vision will position Marchon best for sustainable growth while furthering our mission to help America and the world see better, look better, and feel better.

What does Marchon offer ECPs that can help them grow their business today?

Marchon has always focused on a clear mission to offer innovative designs from exciting brands that are accessibly priced, while providing world-class service. But Marchon is about so much more than that today. Marchon is also an integral part of the VSP Global Premier Program, which connects VSP members and VSP network doctors, providing more opportunities for revenue. Additionally, our Altair subsidiary has established one of its missions to help practices improve their cash flow and they are doing that incredibly well.

What are the biggest opportunities for ECPs with Marchon’s products?

Each and every brand in our portfolio serves a purpose and specific segment of the market. Whether it’s in high-end fashion, performance, or lifestyle, our brands can very well justify their board space by meeting very specific customer needs. Right now, brands like Calvin Klein, Nike, Chloé, Salvatore Ferragamo, and Flexon are enjoying renewed momentum and are turning faster and faster. The newest brand in our portfolio, Longchamp, is off to a terrific start and given its very accessible price points, it is poised to become one of the most successful new brand launches in recent years.

What is your view of the biggest challenges facing ECPs in the U.S.?

Doctors tell us one of the biggest challenges they face is attracting more new patients and offering them a differentiated experience.

How can ECPs address these challenges?

The Premier Program helps today’s independent practice attract new patients with valuable products and services and ways for VSP members to maximize their benefit. In fact, practices that are part of the Premier Program average 34% more new VSP patients, compared to 22% more for those not part of the program.